ADMETatlas
Peptide developability and safety evidence, organized for inspection.
Search by peptide sequence, drug product, endpoint, assay context, PMID, NCT, or measurement. The database keeps conditions, confidence, and provenance close to every result.
Atlas at a glance
Open accessA live data surface for peptide evidence.
Five connected layers — from peptide identity to the evidence and context behind every number. Each node opens that layer's records.
- 36,327canonical peptides01 · Identity
- 110drug products02 · Product context
- 27endpoint definitions17 measured · 10 computed03 · ADMET properties
- 39,523measurements04 · Measured values
- 3,678context signals05 · Interpretation
Evidence by ADMET domain39,523 measurements
- Exposure2%
- Distribution28%
- Stability9%
- Persistence3%
- Safety58%
Overview
How ADMETatlas turns scattered data into traceable evidence.
Evidence from public databases, regulatory labels and trial registries is harmonized, resolved to stable identities, governed, and released as one versioned atlas — curated, experimental, and traceable to the original source.
Comprehensive coverage · Developability + safety · Resolved identity · User-friendly design
A peptide ADMET resource
built to be trusted.
Anatomy of a measurement
Every number keeps the conditions and citation behind it.
This is one real measurement from the atlas — the peptide, the assay it was measured in, the value with its units, and the reference you can follow, all kept together. Nothing is flattened away.
- Peptide identity
- ExenatideHGEGTFTSDLSK…PPPS
- Product context
- ExenatideMarketed GLP-1 receptor agonist
- Endpoint
- Half-lifePK / exposure
- Assay context
- Mouse (ICR) · Exenatide ELISA · retro-orbital sinusConditions kept with the value
Measured value
78 min
4,680 s as recorded